Pacific Biosciences Down 9% as FTC Challenges Sale to Illumina

Date : 12/17/2019 @ 10:32PM
Source : Dow Jones News
Stock : Pacific Biosciences of California Inc (PACB)
Quote : 2.9853  -0.0147 (-0.49%) @ 5:28PM

Pacific Biosciences Down 9% as FTC Challenges Sale to Illumina

Pacific Biosciences of C... (NASDAQ:PACB)
Historical Stock Chart

6 Months : From Oct 2019 to Apr 2020

Click Here for more Pacific Biosciences of C... Charts.

By Josh Beckerman

 

Pacific Biosciences of California Inc. (PACB) shares fell 9% after hours to $4.85 as the Federal Trade Commission said it is challenging the company's $1.2 billion sale to Illumina Inc. (ILMN).

The deal was disclosed in November 2018. In January, Pacific Biosciences said the FTC requested additional information on the transaction.

 

Write to Josh Beckerman at josh.beckerman@wsj.com

 

(END) Dow Jones Newswires

December 17, 2019 17:17 ET (22:17 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest PACB Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.